Drawing for AGE ZERO

USPTO serial 86923006

AGE ZERO

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
KEAN, AMY C
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with AGE ZERO?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Michelle L. Mehok

MICHELLE L. MEHOK PILLSBURY WINTHROP SHAW PITTMAN LLP12255 EL CAMINO REAL, SUITE 300SAN DIEGO, CA 92130UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Umbilical cord stem cells for medical or veterinary use; Pharmaceutical preparations for use in tissue engineered and cell based veterinary and medical therapies for use in the treatment of osteoarthritis, neurologic conditions, inflammatory conditions, immune-mediated conditions, endocrine diseases, chronic degenerative diseases, gastrointestinal diseases; Pharmaceutical preparations manufactured or modified by genetic engineering in the form of umbilical cord stem cells for veterinary and medical purposes; Pharmaceutical and veterinary preparations, namely, gene therapy products in the form of umbilical cord stem cells for therapeutic medical use; Biochemical preparations for medical or veterinary purposes, namely, preparations for use in gene therapy for the treatment of osteoarthritis, neurologic conditions, inflammatory conditions, immune-mediated conditions, endocrine diseases, chronic degenerative diseases, gastrointestinal diseases; umbilical cord stem cells for clinical use; Orthobiologic preparations, namely, biologic preparations in the nature of umbilical cord stem cells to achieve symptomatic relief and cures from various orthopedic diseases; Pharmaceutical preparations for the treatment of osteoarthritis; pharmaceutical preparations for the treatment of spinal cord injuryACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
May 14, 2018MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
May 14, 2018ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Oct 12, 2017EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Oct 10, 2017EX2GSOU EXTENSION 2 GRANTED—
Oct 10, 2017EXT2SOU EXTENSION 2 FILED—
Oct 10, 2017EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Apr 14, 2017EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Apr 11, 2017EX1GSOU EXTENSION 1 GRANTED—
Apr 11, 2017EXT1SOU EXTENSION 1 FILED—
Apr 11, 2017EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Oct 11, 2016NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Aug 16, 2016NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 16, 2016PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 27, 2016NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jul 7, 2016CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 7, 2016XAECEXAMINER'S AMENDMENT ENTERED—
Jul 7, 2016GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jul 7, 2016GNEAEXAMINERS AMENDMENT E-MAILED—
Jul 7, 2016CNEAEXAMINERS AMENDMENT -WRITTEN—
Jun 3, 2016GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 3, 2016GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 3, 2016CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 19, 2016DOCKASSIGNED TO EXAMINER—
Mar 3, 2016NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 3, 2016NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance